Background: Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and
the second most lethal malignancy worldwide. In the Western world, HCC predominantly …

Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third cause of
tumor associated deaths worldwide. HCC incidence rates are increasing in many parts of …

Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an
increasing incidence. With advances in surgical techniques and instrumentation and the …

Background Hepatocellular carcinoma (HCC) remains one of the most common neoplasms
worldwide. Curative treatment options include liver transplantation or resection …

Hepatocellular carcinoma (HCC) is the second most common cause of cancer death
worldwide. This cancer commonly arises against a background of chronic liver disease. As a …

Management of hepatocellular carcinoma (HCC) has been continuously evolving during
recent years. HCC is a worldwide clinical and social issue and typically a complicates …

The management of hepatocellular carcinoma (HCC) is decided according to evidence‐
based recommendations generated by international societies: according to these …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death, especially in
Eastern areas. With advancements in diagnosis and treatment modalities for HCC, the …

Hepatocellular carcinoma (HCC) is frequently diagnosed at advanced stages and has a
high mortality rate. With improved survival of patients with cirrhotic liver disease and …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related morbidity and
mortality worldwide, largely as a result of 3 main factors:(1) competing risk of cirrhosis, which …